"
Team:Tsinghua
From 2014.igem.org
(Difference between revisions)
| Line 18: | Line 18: | ||
<span> | <span> | ||
<div id="image1" class="floating"> | <div id="image1" class="floating"> | ||
| - | <img src="../ | + | <img src="https://static.igem.org/mediawiki/2014/6/63/Tsinghua_Emoji-4.png" width="200" height="250" alt=""/> |
</div> | </div> | ||
<div id="text1" class="slideLeft"> | <div id="text1" class="slideLeft"> | ||
| Line 26: | Line 26: | ||
</div> | </div> | ||
<div class="arrow"> | <div class="arrow"> | ||
| - | <img src=" | + | <img src="https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png" width="22" height="27" alt=""/> |
<p>Scroll down</p> | <p>Scroll down</p> | ||
</div> | </div> | ||
| Line 34: | Line 34: | ||
<span> | <span> | ||
<div id="image2" class="tossing"> | <div id="image2" class="tossing"> | ||
| - | <img src="../ | + | <img src="https://static.igem.org/mediawiki/2014/2/23/Tsinghua_Emoji-2.png" width="200" height="250" alt=""/> |
</div> | </div> | ||
<div id="text2"> | <div id="text2"> | ||
| Line 42: | Line 42: | ||
</div> | </div> | ||
<div class="arrow"> | <div class="arrow"> | ||
| - | <img src=" | + | <img src="https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png" width="22" height="27" alt=""/> |
<p>Scroll down</p> | <p>Scroll down</p> | ||
</div> | </div> | ||
| Line 50: | Line 50: | ||
<span> | <span> | ||
<div id="image3"> | <div id="image3"> | ||
| - | <img src="../ | + | <img src="https://static.igem.org/mediawiki/2014/4/4a/Tsinghua_Logo300x409.png" width="150" height="204.5" alt=""/> |
</div> | </div> | ||
<div id="text3"> | <div id="text3"> | ||
| Line 58: | Line 58: | ||
</div> | </div> | ||
<div class="arrow"> | <div class="arrow"> | ||
| - | <img src=" | + | <img src="https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png" width="22" height="27" alt=""/> |
<p>Scroll down</p> | <p>Scroll down</p> | ||
</div> | </div> | ||
Revision as of 20:48, 14 October 2014
Scroll down
T1DM results from the autoimmune destruction of insulin-producing beta cells in the pancreas. We aim to convert somatic cells into insulin-producing cells regulated by blood glucose, and eliminate the need for constant insulin therapy.
Scroll down
We use Adeno-associated viral (AAV) vectors to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more?
Scroll down
